Page last updated: 2024-08-21

oxazoles and Left Ventricular Hypertrophy

oxazoles has been researched along with Left Ventricular Hypertrophy in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (33.33)18.2507
2000's5 (55.56)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agostinucci, K; Colton, HM; Dunn, ME; Engle, SK; Gallacher, M; Gropp, KE; King, NM; Manfredi, TG; More, V; Powe, J; Rodriguez, LA; Serra, D; Shimpi, P; Vetter, FJ1
Avanza, AC; Mansur, AP; Ramires, JA1
Borbás, S; Dienes, BS; Farsang, C; Lengyel, M; Zorándi, A1
Ayan, F; Ikitimur, B; Koldas, L1
Bousquet, PP; Monassier, LJ; Signolet, IL1
DeLuca, N; Lorino, G; Rosiello, G; Rubattu, S; Sarno, D; Trimarco, B; Volpe, M1
Argenziano, L; De Luca, N; Iovino, G; Morisco, C; Russo, R; Sarno, D; Trimarco, B; Volpe, M1
Balazovjech, I; Dubai, G; Dvorak, I; Januszewicz, W; Krupa-Wojciechowska, B; Kubasik, A; Kuch-Wocial, A; Polak, G; Sadowski, Z; Simon, K; Stejfa, M; Szwed, H1
Reid, JL1

Reviews

1 review(s) available for oxazoles and Left Ventricular Hypertrophy

ArticleYear
Rilmenidine: a clinical overview.
    American journal of hypertension, 2000, Volume: 13, Issue:6 Pt 2

    Topics: Albuminuria; Animals; Antihypertensive Agents; Diabetic Angiopathies; Humans; Hyperlipidemias; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Oxazoles; Rilmenidine; Treatment Outcome

2000

Trials

4 trial(s) available for oxazoles and Left Ventricular Hypertrophy

ArticleYear
Efficacy of exercise, losartan, enalapril, atenolol and rilmenidine in subjects with blood pressure hyperreactivity at treadmill stress test and left ventricular hypertrophy.
    Journal of human hypertension, 2009, Volume: 23, Issue:4

    Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Enalapril; Exercise Test; Exercise Therapy; Female; Humans; Hypertrophy, Left Ventricular; Losartan; Male; Oxazoles; Renin-Angiotensin System; Rilmenidine; Sympathetic Nervous System

2009
Effects of one-year treatment with rilmenidine on systemic hypertension-induced left ventricular hypertrophy in hypertensive patients.
    The American journal of cardiology, 1994, Dec-22, Volume: 74, Issue:13

    Topics: Antihypertensive Agents; Atrial Natriuretic Factor; Echocardiography; Female; Forearm; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Oxazoles; Renin; Rilmenidine; Vascular Resistance

1994
Rilmenidine in patients with left ventricular hypertrophy: beyond the reduction of left ventricular mass.
    Journal of cardiovascular pharmacology, 1995, Volume: 26 Suppl 2

    Topics: Antihypertensive Agents; Atrial Natriuretic Factor; Drug Administration Schedule; Electrolytes; Female; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Oxazoles; Renin; Rilmenidine

1995
Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1998, Volume: 16, Issue:3

    Topics: Adult; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diastole; Double-Blind Method; Echocardiography; Electrocardiography, Ambulatory; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Nifedipine; Oxazoles; Rilmenidine; Treatment Outcome

1998

Other Studies

4 other study(ies) available for oxazoles and Left Ventricular Hypertrophy

ArticleYear
Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy.
    Toxicologic pathology, 2017, Volume: 45, Issue:2

    Topics: Animals; Biomarkers; Cardiotoxicity; Diagnosis, Differential; Hypertrophy, Left Ventricular; Male; Natriuretic Peptides; Oxazoles; PPAR gamma; Rats, Sprague-Dawley; Swimming; Tyrosine; Ventricular Function, Left; Ventricular Remodeling

2017
Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
    Current medical research and opinion, 2003, Volume: 19, Issue:3

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Echocardiography; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Oxazoles; Perindopril; Rilmenidine

2003
Short-term effects of rilmenidine on left ventricular hypertrophy and systolic and diastolic function in patients with essential hypertension: comparison with an angiotensin converting enzyme inhibitor and a calcium antagonist.
    Japanese heart journal, 2003, Volume: 44, Issue:5

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diastole; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Oxazoles; Rilmenidine; Systole; Ventricular Function, Left

2003
Improvement of cardiac diastolic function by long-term centrally mediated sympathetic inhibition in one-kidney, one-clip hypertensive rabbits.
    American journal of hypertension, 2008, Volume: 21, Issue:1

    Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Cardiomyopathies; Diastole; Disease Models, Animal; Heart Rate; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Ligation; Male; Metoprolol; Myocardial Contraction; Nephrectomy; Oxazoles; Rabbits; Renal Artery; Rilmenidine; Sympathetic Nervous System; Systole; Time Factors; Ultrasonography; Ventricular Function; Ventricular Remodeling

2008